Skip to content
Search AI Powered

Latest Stories

RPS launches largest edition of Medicines, Ethics and Practice

RPS launches largest edition of Medicines, Ethics and Practice

The MEP now incorporates guidance from the new RPS Patient Safety Professional standards

The Royal Pharmaceutical Society (RPS) has launched its latest edition of Medicines, Ethics and Practice (MEP), marking it as the largest ever at 258 pages—reflecting a substantial 30 per cent increase in content from the previous edition.

Key updates in this year’s edition include expanded prescribing content, new patient safety standards, a joint position statement by RPS and RCN, and updated information on Valproate Pregnancy Prevention Programme (PPP).


Rakhee Amin, MEP Editor, said: “The MEP continues to support our members and the wider pharmacy profession. The additions of prescribing and patient safety reflect our ongoing commitment to high standards of professional practice.

“We thank everyone who helped build this edition of the MEP, and those who provided expert advice and information during its preparation.”

The MEP now includes detailed signposting to RPS resources and the full text of RPS competency frameworks and guidance, such as the Competency Framework for All Prescribers, the Competency Framework for Designated Prescribing Practitioners, and the Professional Guidance on Expanding Prescribing Scope of Practice.

The latest edition also incorporates guidance from the new RPS Patient Safety Professional standards, designed to support pharmacists in reporting adverse effects and handling dispensing errors more effectively.

These standards have been developed by the RPS, Association of Pharmacy Technicians UK and Pharmacy Forum NI, with the support of an expert steering group and public consultation.

In collaboration with the Royal College of Nursing (RCN), the RPS has added updated information and guidance on the safe practice of prescribing, dispensing, supply, and administration by the same individual.

Additionally, the 47 edition includes updated information on the valproate pregnancy prevention programme, incorporating new legislation and the most recent MHRA guidance on full pack dispensing of valproate-containing medicines.

All Foundation Trainee Members of the RPS will receive a copy of the new MEP free of charge as part of their membership. Copies are available for £52.50 for members and £70 for non-members.

Additionally, all currently practising GB-based pharmacists (excluding Student, Retired, or International Members) can request a free physical copy by completing a quick 4-question form available in the Printed Materials Opt-In section on www.rpharms.com/myRPS.

All RPS members, regardless of their membership type, can access the digital MEP.

More For You

New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less